Fish oil compound may unclog inflamed arteries in obese patients
NCT ID NCT07038252
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a dietary supplement made from omega-3 fatty acids (called SPM) can reduce blood vessel damage caused by inflammation in people with obesity and high blood pressure. Researchers will give 60 participants either the supplement or a placebo for 12 weeks and measure how well their arteries expand. The goal is to see if boosting the body's natural inflammation-resolution process can lower the leftover heart risk that standard treatments don't fix.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Pharmacologie - UF Pharmacologie Clinique
RECRUITINGParis, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?